Similar Items: Testing Van Gool’s Hypothesis: A Method to Predict Side Effects of Cholinesterase Inhibitors in Patients with Cellular Degenerative and Vascular Dementia
- Advances in pharmacotherapy for vascular cognitive impairment and vascular dementia: An update of 2025
- Vascular cognitive impairment and dementia drug‐development pipeline 2025
- Druggable genome‐wide Mendelian randomization analysis identifies potential treatment targets in vascular dementia
- Diversity and inclusivity in Australian dementia prevention research: A mixed methods review
- Pharmacogenetic analyses in people with dementia in Northeast Germany
- Outcome Measures for Dementia in the Advanced Stage and at the End of Life